Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma

Recruiting now

Conditions studied: Ewing Sarcoma

In brief

assess whether there is a correlation between some factors (age, sex, tumor volume, tumor site, chemotherapy-induced necrosis, radiation and biomarkers) and overall survival (OS) and relapse-free survival (RFS) in patients with Ewing sarcoma. Identification of reliable prognostic factors could help to identify high-risk patients, which may require a different treatment and follow up.

Key facts

Study ID

NCT06243588

Run by

Istituto Ortopedico Rizzoli

People needed

400

Starts

2024-01-25

Expected to finish

2025-12-31

Last updated by the study team

2025-03-05

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female patients treated at Rizzoli Orthopaedic Institute between 01/01/1991 and 31/12/2021
• Age ≥ 2 years
• Diagnosis of Ewing Sarcoma
• Patients with available clinical and imaging data

You may not qualify if…

• At least one inclusion criterion not met

Where it is running

• IRCCS Itituto Ortopedico Rizzoli — Bologna, BO, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.